NFKB1 and systemic lupus erythematosus: In SLE patients, NF-κB activation can lead to the production of pro-inflammatory cytokines (IL-6, TNF-α) and recruitment of immune cells (T cells and macrophages) to the kidneys, promoting kidney inflammation and damage [30].